Ambulatory Blood Pressure Monitoring > 자유게시판

End-organ damage related to hypertension is more intently related to ambulatory blood strain (ABP) than clinic or informal blood pressure measurements. ABP measurements give higher prediction of clinical outcome than clinic or casual blood stress measurements. The technique of ABP monitoring (ABPM) is specialised; validated displays and appropriate high quality management measures should be used. Interpretation of ABP profile should embrace imply daytime, evening-time (sleep) and 24-hour measurements, and consideration of diary information and time of drug therapy. Reports may additionally include ABP "masses" (percentage space beneath the blood strain curve above set limits) for daytime and evening-time periods. Percentage space underneath the blood stress curve above set limits. Can only be detected by ambulatory blood stress monitoring (ABPM) or self-monitoring. May not be benign; definitive outcome research are wanted. Requires continued surveillance, involving self-monitoring and repeat ABPM at 1-2-12 months intervals. Does not reply to standard drug therapy. Department of Vascular Sciences, Dandenong Hospital, Dandenong, VIC. 1. Verdecchia P, Clement D, Faggard R, et al.

Blood Pressure Monitoring. Task power III. Target organ damage, morbidity and mortality. 2. Mancia G, Zanchetti A, Agabiti-Rosei E, et al. Ambulatory blood stress is superior to clinic blood pressure in predicting remedy-induced regression of left ventricular hypertrophy. 3. Perloff D, Sokolow M, Cowan R, et al. Prognostic value of ambulatory blood pressure measurements: further evaluation. J Hypertens 1989; l 7: S3-S10. 4. Verdecchia P. Prognostic value of ambulatory blood stress. Current evidence and clinical implications. 5. Imai Y. Prognostic significance of ambulatory blood stress. 6. Staessen J, Thijs L, Fagard R, et al. Predicting cardiovascular risk utilizing conventional vs ambulatory blood strain in older patients with systolic hypertension. 7. Sokolow M, Werdegar D, Kain H, Hinman A. Relationship between level of blood strain measured casually and by portable recorders and severity of complications in important hypertension. 8. O'Brien E, Petrie J, Littler WA, et al. The British Hypertension Society protocol for the evaluation of blood stress measuring devices.

J Hypertens 1993; 11: S43-S63. 9. Association for the Advancement of Medical Instrumentation. American National Standard. Electronic or automated sphygmomanometer. ANSI/AAMI SP 10-1992. Arlington, VA. 10. O'Brien E, Coats A, Owens P, et al. Use and interpretation of ambulatory blood strain monitoring: recommendations of the British Hypertension Society. 11. O'Brien E, Waeber B, Parati G, et al. Blood pressure measuring devices: suggestions of the European Society of Hypertension. 12. O'Brien E. State of the market for devices for blood strain measurement. 13. White WB. Blood strain load and goal organ effects in patients with important hypertension. J Hypertens 1991; 9: S39-S41. 14. Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood strain. An impartial predictor of prognosis in important hypertension. 15. Steptoe A, Cropley M, Joekes K. Job strain, blood pressure and response to uncontrollable stress. 16. Joint National Committee on Detection, Evaluation and Treatment of Hypertension. The sixth report of the Joint National Committee.

17. Guidelines Subcommittee. World Health Organization-International Society of Hypertension guidelines for the management of hypertension. 18. Pickering T, for the American Society of Hypertension Ad-hoc Panel. Recommendations for using dwelling (self) and ambulatory blood pressure monitoring. 19. Myers MG, Haynes RB, Rabkin SW. Canadian Hypertension Society pointers for ambulatory blood stress monitoring. 20. Staessen J, Beilin L, Parati G, et al. Task pressure IV: Clinical use of ambulatory blood strain monitoring. 21. Staessen JA, Bytterbier G, Buntinx F, et al, for the Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators. Antihypertensive remedy primarily based on conventional or ambulatory blood strain measurement: a randomized controlled trial. 22. Beltman F, Hessen W, Kok R, et al. Predictive value of ambulatory blood stress shortly after withdrawal of antihypertensive medicine in primary care patients. 23. McGrath BP. Is white coat hypertension innocent? 24. Staessen J, O'Brien E, Atkins N, et al. Ambulatory blood pressure in normotensive compared with hypertensive topics. 25. Mancia G, Sega R, Bravi C, et al.

Ambulatory blood strain normality: outcomes from the PAMELA research. 26. Ohkubo T, Imai Y, Tsuju I, et al. Reference values for 24-hour ambulatory blood stress monitoring based on a prognostic criterion: the Ohasama Study. 27. Lurbe E, Redon J, Liao Y, et al. Ambulatory blood strain monitoring in normotensive kids. 28. Brown MA, Robinson A, Bowyer L, et al. Ambulatory blood stress monitoring in pregnancy: what's regular ? 29. Silagy C, McNeil J, Farish S, McGrath B. Comparison of repeated measures of ambulatory and clinic blood strain readings in isolated systolic hypertension. 30. Pickering T, James G, Boddie C, et al. How common is white coat hypertension. 31. Palatini P, Dorigatti F, Roman E, et al. White-coat hypertension: a variety bias? 32. Palatini P, Mormino P, Santonastaso M, et al. Target-organ injury in stage I hypertensive topics with white coat and BloodVitals test sustained hypertension: outcomes from the HARVEST examine. 33. Kario K, Shimada K, Schwartz J, et al. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. 34. Herpin D, Pickering T, BloodVitals test Sterglou G, et al. Consensus conference on self-blood stress measurement. Clinical applications and analysis. 35. Self measurement of blood pressure -- a paper for health professionals. 36. Ewald B, Pekarsky B. Cost evaluation of ambulatory blood strain monitoring in initiating antihypertensive drug remedy in Australian basic practice. 37. National Health and Medical Research Council. Guidelines for the event and implementation of clinical apply tips. Publication of your on-line response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by e mail within five working days ought to your response be accepted.